Published in Calcif Tissue Int on September 01, 1999
Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int (2010) 2.69
Effects of non-enzymatic glycation on cancellous bone fragility. Bone (2006) 1.87
Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links. Bone (2005) 1.53
Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. Bone (2009) 1.47
Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra. Osteoporos Int (2007) 1.47
Structural basis of growth-related gain and age-related loss of bone strength. Rheumatology (Oxford) (2008) 1.26
Methods for assessing bone quality: a review. Clin Orthop Relat Res (2011) 1.22
Aging and bone. J Dent Res (2010) 1.20
Age-related factors affecting the postyield energy dissipation of human cortical bone. J Orthop Res (2007) 1.20
Role of collagen and other organics in the mechanical properties of bone. Osteoporos Int (2003) 1.16
The effect of the microscopic and nanoscale structure on bone fragility. Osteoporos Int (2008) 1.07
In situ accumulation of advanced glycation endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption. Bone (2011) 1.04
Age-related effect on the concentration of collagen crosslinks in human osteonal and interstitial bone tissue. Bone (2006) 0.98
The contribution of collagen crosslinks to bone strength. Bonekey Rep (2012) 0.92
Fractures among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer (2012) 0.92
Characterization of the effects of x-ray irradiation on the hierarchical structure and mechanical properties of human cortical bone. Biomaterials (2011) 0.92
Lumbar trabecular bone mineral density distribution in patients with and without vertebral fractures: a case-control study. Eur Spine J (2014) 0.85
Thinking inside and outside the envelopes of bone: dedicated to PDD. Osteoporos Int (2009) 0.82
Water Soluble Components of 'Osteocare' Promote Cell Proliferation, Differentiation, and Matrix Mineralization in Human Osteoblast-Like SaOS-2 Cells. Sci Pharm (2014) 0.81
Distinct characteristics of mandibular bone collagen relative to long bone collagen: relevance to clinical dentistry. Biomed Res Int (2014) 0.80
The application of backscattered ultrasound and photoacoustic signals for assessment of bone collagen and mineral contents. Quant Imaging Med Surg (2015) 0.80
Importance of age on the dynamic mechanical behavior of intertubular and peritubular dentin. J Mech Behav Biomed Mater (2014) 0.78
Modifications in bone matrix of estrogen-deficient rats treated with intermittent PTH. Biomed Res Int (2015) 0.77
Osteocytic connexin 43 is not required for the increase in bone mass induced by intermittent PTH administration in male mice. J Musculoskelet Neuronal Interact (2016) 0.77
Interaction between bone and muscle in older persons with mobility limitations. Curr Pharm Des (2014) 0.77
Intrinsic mechanical behavior of femoral cortical bone in young, osteoporotic and bisphosphonate-treated individuals in low- and high energy fracture conditions. Sci Rep (2016) 0.76
The supramolecular structure of bone: X-ray scattering analysis and lateral structure modeling. Acta Crystallogr D Struct Biol (2016) 0.75
Bone quality assessment techniques: geometric, compositional, and mechanical characterization from macroscale to nanoscale. Clin Rev Bone Miner Metab (2016) 0.75
Effects of losartan treatment on the physicochemical properties of diabetic rat bone. J Bone Miner Metab (2016) 0.75
Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology (2001) 3.00
Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res (2001) 2.89
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications. Osteoporos Int (2007) 2.46
Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int (2006) 2.33
Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int (2005) 2.23
Fracture rates and risk factors for fractures in patients with spinal cord injury. Spinal Cord (1998) 2.07
Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2006) 1.79
Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia (2005) 1.79
Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int (2008) 1.78
Fracture risk associated with the use of morphine and opiates. J Intern Med (2006) 1.71
Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res (1993) 1.57
Characterization of the collagen of human hypertrophic and normal scars. Biochim Biophys Acta (1975) 1.56
Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci (Lond) (1979) 1.49
Stereological considerations concerning the measurement of individual osteoid seams and resorption cavities. Bone Miner (1994) 1.47
Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ (2000) 1.47
Statins decrease bone turnover in postmenopausal women: a cross-sectional study. Eur J Clin Invest (2002) 1.46
The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERalpha and ERbeta. J Biol Chem (1999) 1.46
Mechanical properties of adult vertebral cancellous bone: correlation with collagen intermolecular cross-links. J Bone Miner Res (2002) 1.46
Autosomal dominant osteopetrosis. Clin Orthop Relat Res (1993) 1.44
Stroke in relation to use of raloxifene and other drugs against osteoporosis. Osteoporos Int (2010) 1.42
Familial isolated primary hyperparathyroidism. Clin Endocrinol (Oxf) (1994) 1.42
Polymorphisms of muscle genes are associated with bone mass and incident osteoporotic fractures in Caucasians. Calcif Tissue Int (2013) 1.40
Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum bone Gla-protein. Calcif Tissue Int (1989) 1.39
[Costs of different intervention strategies to prevent hip fractures]. Ugeskr Laeger (1999) 1.39
Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int (2006) 1.39
Presence of type III collagen in guinea-pig dermal scar. Biochem J (1976) 1.34
The immunodominant outer membrane antigen of Actinobacillus actinomycetemcomitans is located in the serotype-specific high-molecular-mass carbohydrate moiety of lipopolysaccharide. Infect Immun (1991) 1.33
Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut (2000) 1.33
Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) (2005) 1.30
Collagen polymorphism in experimental granulation tissue. Biochem Biophys Res Commun (1975) 1.30
Vitamin D and its binding protein Gc: long-term variability in peri- and postmenopausal women with and without hormone replacement therapy. Scand J Clin Lab Invest (2006) 1.29
The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects. J Clin Endocrinol Metab (1988) 1.29
Polymer scaffolds fabricated with pore-size gradients as a model for studying the zonal organization within tissue-engineered cartilage constructs. Tissue Eng (2005) 1.26
The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors. Mol Cell Biol (2000) 1.26
Fracture risk in patients treated for hyperthyroidism. Thyroid (2000) 1.25
Sex differences in age-related changes in vertebral body size, density and biomechanical competence in normal individuals. Bone (1990) 1.23
Analysis of collagen status in premenopausal nulliparous women with genuine stress incontinence. Br J Obstet Gynaecol (1997) 1.22
Lumbar vertebral body compressive strength evaluated by dual-energy X-ray absorptiometry, quantitative computed tomography, and ashing. Bone (1999) 1.22
DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors. J Biol Chem (2000) 1.20
Non-enzymic glycation of fibrous collagen: reaction products of glucose and ribose. Biochem J (1995) 1.19
Age- and sex-related changes in iliac cortical bone mass and remodeling. Bone (1994) 1.19
Fractures in patients with primary idiopathic hypothyroidism. Thyroid (2000) 1.17
Biomechanical competence of vertebral trabecular bone in relation to ash density and age in normal individuals. Bone (1987) 1.17
Normal vertebral body size and compressive strength: relations to age and to vertebral and iliac trabecular bone compressive strength. Bone (1986) 1.16
Histomorphometric analysis of normal bone from the iliac crest. Acta Pathol Microbiol Scand A (1978) 1.16
Partial characterization of a second basement membrane collagen in human placenta. Evidence for the existence of two type IV collagen molecules. FEBS Lett (1979) 1.15
Vitamin D insufficiency in Greenlanders on a westernized fare: ethnic differences in calcitropic hormones between Greenlanders and Danes. Calcif Tissue Int (2003) 1.14
Reconstruction of the formative site in iliac trabecular bone in 20 normal individuals employing a kinetic model for matrix and mineral apposition. Metab Bone Dis Relat Res (1984) 1.14
Fracture risk is increased in epilepsy. Acta Neurol Scand (1999) 1.13
Tetracycline double-labeling of iliac trabecular bone in 41 normal adults. Calcif Tissue Res (1978) 1.12
Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis. Bone (1996) 1.11
Missing observations in bone histomorphometry on osteoporosis: implications and suggestions for an approach. Bone (1999) 1.10
Stretch receptor-associated expression of alpha 3 isoform of the Na+, K+-ATPase in rat peripheral nervous system. Neuroscience (2003) 1.10
Biochemistry and histology of the connective tissue of Dupuytren's disease lesions. Eur J Clin Invest (1980) 1.10
Trabecular bone remodeling and balance in primary hyperparathyroidism. Bone (1986) 1.10
Effects of 25OHD concentrations on chances of pregnancy and pregnancy outcomes: a cohort study in healthy Danish women. Eur J Clin Nutr (2012) 1.09
Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS). Osteoporos Int (2011) 1.08
Humoral immune responses to Porphyromonas gingivalis before and following therapy in rapidly progressive periodontitis patients. J Periodontol (1991) 1.07
Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics. Bone Miner (1994) 1.07
A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. Bone (1989) 1.06
Fracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritis. Calcif Tissue Int (2006) 1.06
Chemistry of collagen cross-links: glucose-mediated covalent cross-linking of type-IV collagen in lens capsules. Biochem J (1993) 1.06
Reduced relative risk of fractures among users of lithium. Calcif Tissue Int (2005) 1.05
Post-translational modifications in the collagen of human osteoporotic femoral head. Biochem Biophys Res Commun (1992) 1.05
Age related changes in the non-collagenous components of the extracellular matrix of the human lamina cribrosa. Br J Ophthalmol (2000) 1.05
Changes in collagen cross-linking in degenerative disc disease and scoliosis. Spine (Phila Pa 1976) (1998) 1.05
Chemistry of the collagen cross-links. Nature of the cross-links in the polymorphic forms of dermal collagen during development. Biochem J (1976) 1.04
Age-related differences between thinning of horizontal and vertical trabeculae in human lumbar bone as assessed by a new computerized method. Bone (2002) 1.03
An evaluation of the quantitative parameters applied in bone histology. Acta Pathol Microbiol Scand A (1978) 1.02
Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study. J Bone Miner Res (2003) 1.02
Low serum levels of 1.25-dihydroxyvitamin D and histomorphometric evidence of osteomalacia after jejunoileal bypass for obesity. Gut (1980) 1.01
Defective neutrophil and monocyte motility in patients with early onset periodontitis. Infect Immun (1985) 1.01
Biochemical changes in the collagen of human osteoporotic bone matrix. Connect Tissue Res (1993) 1.01
Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish Osteoporosis Prevention Study. Maturitas (2000) 1.00
Ultrastructural investigations of bone resorptive cells in two types of autosomal dominant osteopetrosis. Bone (1994) 1.00
Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. Osteoporos Int (2010) 0.99
Correlation between the compressive strength of iliac and vertebral trabecular bone in normal individuals. Bone (1985) 0.99
Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcif Tissue Int (2005) 0.99
Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial. Osteoporos Int (2014) 0.99
Cortical bone mass, composition, and mechanical properties in female rats in relation to age, long-term ovariectomy, and estrogen substitution. Calcif Tissue Int (1993) 0.98
A model of vertebral trabecular bone architecture and its mechanical properties. Bone (1990) 0.98
Lysophosphatidic acid cooperates with 1alpha,25(OH)2D3 in stimulating human MG63 osteoblast maturation. Prostaglandins Other Lipid Mediat (2006) 0.98
Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin Endocrinol (Oxf) (2007) 0.98
Reconstruction of the resorptive site in iliac trabecular bone: a kinetic model for bone resorption in 20 normal individuals. Metab Bone Dis Relat Res (1984) 0.97
Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int (1993) 0.97
Estimation of the three-dimensional wall thickness of completed remodeling sites in iliac trabecular bone. Metab Bone Dis Relat Res (1982) 0.97
Age- and gender-related differences in vertebral bone mass, density, and strength. J Bone Miner Res (1999) 0.97
Primary hyperparathyroidism: short-term changes in bone remodeling and bone mineral density following parathyroidectomy. Bone (1999) 0.96